FindTrial
Sign In

In Laparoscopic cholecystectomy patients ,for post operative pain relief,use of local anaesthetic Ropicavaine.

A Comparative Evaluation of Pre-emptive versus Post- Surgery Intraperitoneal Instillation of 0.5% Ropivacaine 30ml for Post-Operative Pain relief in Laparoscopic cholecystectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027799
Enrollment
100
Registered
2020-09-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K811- Chronic cholecystitis

Interventions

Intervention1: Intraperitoneal Instillation of 0.5% Ropivacaine in Laparoscopic Cholecystectomy cases: In Laparoscopic Cholecystectomy case,there will be Instillation of 0.5% Ropivacaine 30 ml and 30m

Sponsors

DrSNMedical College and associated group of Hospitals Jodhpur Rajasthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Chronic Laparoscopic cholecystectomy ASA GRADE 1 and 2

Exclusion criteria

Exclusion criteria: History of Hypersensitivity reaction to drug,surgery being converted into open cholecystectomy,drain after surgery, acute cholecystitis ,acute pancreatitis,ASA grade more than 2, Pregnancy,any psychiatric illness, patient refusal to participate in study

Design outcomes

Primary

MeasureTime frame
To compare effect of intraperitoneal instillation of Ropivacaine, Pre-emptive and Post-surgery for post operative pain relief in Laparoscopic Cholecystectomy and study focus on reduce use of Analgesics and opioids in post operative period for pain relief and register the time when first need of rescue analgesia will be observed.Timepoint: December 2020—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactDrHimanshu Sharma

Department of Anaesthesiology,Dr.S.N.Medical College and associated group of hospitals, Jodhpur

drshobhaujwal@gmail.com9461028789

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026